These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8106637)

  • 1. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity.
    Nolan JJ; Freidenberg G; Henry R; Reichart D; Olefsky JM
    J Clin Endocrinol Metab; 1994 Feb; 78(2):471-7. PubMed ID: 8106637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.
    Freidenberg GR; Reichart D; Olefsky JM; Henry RR
    J Clin Invest; 1988 Oct; 82(4):1398-406. PubMed ID: 3170749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.
    Freidenberg GR; Suter SL; Henry RR; Reichart D; Olefsky JM
    J Clin Invest; 1991 Jun; 87(6):2222-9. PubMed ID: 1645756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
    Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
    Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.
    Kusari J; Kenner KA; Suh KI; Hill DE; Henry RR
    J Clin Invest; 1994 Mar; 93(3):1156-62. PubMed ID: 8132755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.
    Caro JF; Sinha MK; Raju SM; Ittoop O; Pories WJ; Flickinger EG; Meelheim D; Dohm GL
    J Clin Invest; 1987 May; 79(5):1330-7. PubMed ID: 3033021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.
    Nyomba BL; Ossowski VM; Bogardus C; Mott DM
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E964-74. PubMed ID: 2163202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.
    Davis SN; Monti L; Piatti PM; Moller N; Ng L; Coppack S; May M; Brown MD; Orskov H; Alberti KG
    Diabetes Res; 1993; 23(1):1-18. PubMed ID: 7924144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity.
    Gumbiner B; Thorburn AW; Henry RR
    J Clin Endocrinol Metab; 1991 Apr; 72(4):801-7. PubMed ID: 2005204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
    Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
    J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance. Receptor and post-receptor abnormalities].
    Liguori M; Urso R; Fatigante G
    Minerva Endocrinol; 1998 Jun; 23(2):37-52. PubMed ID: 9844354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.